Fig. 7From: Genetic correction of concurrent α- and β-thalassemia patient-derived pluripotent stem cells by the CRISPR-Cas9 technologyCFU-E colony formation. A Representative image of CFU-E. Scale bars = 200 µm. B The number of CFU-E formed by hiPSCs after the repair was significantly higher than that no corrected hiPSCsBack to article page